Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-21-000055
Filing Date
2021-04-27
Accepted
2021-04-27 14:44:19
Documents
34
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT -MARCH 31, 2021 bfnh04262021form10qmar2021.htm 10-Q 132598
2 CERTIFICATION ex311.htm EX-31.1 4757
3 CERTIFICATION ex312.htm EX-31.2 4956
4 CERTIFICATION ex321.htm EX-32.1 2021
5 CERTIFICATION ex322.htm EX-32.2 1931
12 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-21-000055.txt   1034569

Data Files

Seq Description Document Type Size
6 bfnh-20210331.xml EX-101.INS 77223
7 bfnh-20210331.xsd EX-101.SCH 15292
8 bfnh-20210331_cal.xml EX-101.CAL 25282
9 bfnh-20210331_def.xml EX-101.DEF 47948
10 bfnh-20210331_lab.xml EX-101.LAB 110477
11 bfnh-20210331_pre.xml EX-101.PRE 86721
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 21858293
SIC: 3826 Laboratory Analytical Instruments